This post was originally published on this site
The rising geriatric population, increasing healthcare expenditures, and advances in various drug discoveries have contributed to bullish investor sentiment. This is evident from the iShares Biotechnology ETF’s (IBB) 27.4% return over the past year.
Considering the industry’s promising growth prospects, Wall Street Analysts expect biotechnology stocks Kura Oncology (KURA) and Corvus Pharmaceuticals Inc . (CRVS) to deliver exceptional returns in upcoming months.